Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)1A.J.A. and R.K. contributed equally to this work.-Reference-Cited by-同舟云学术

Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)1A.J.A. and R.K. contributed equally to this work.

Published:2014-11 Issue:8 Volume:32 Page:1308-1316
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Armstrong Andrew J.,Kaboteh Reza,Carducci Michael A.,Damber Jan-Erik,Stadler Walter M.,Hansen Mats,Edenbrandt Lars,Forsberg Göran,Nordle Örjan,Pili Roberto,Morris Michael J.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference20 articles.

1. Quality of planar whole-body bone scan interpretations—a nationwide survey;Sadik;Eur J Nucl Med Mol Imaging,2008

2. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group;Scher;J Clin Oncol,2008

3. Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response;Ryan;Clin Cancer Res,2011

4. Quantitative bone metastases analysis based on image segmentation;Erdi;J Nucl Med,1997

5. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the bone scan index;Ulmert;Eur Urol,2012

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flare phenomenon visualized by 99mTc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer;Annals of Nuclear Medicine;2024-03-13

2. Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer;JCO Precision Oncology;2024-02

3. The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study;Biomedicines;2023-04-05

4. Freely Available, Fully Automated AI-Based Analysis of Primary Tumour and Metastases of Prostate Cancer in Whole-Body [18F]-PSMA-1007 PET-CT;Diagnostics;2022-08-30

5. Segmented linear correlations between bone scan index and prostate cancer biomarkers, alkaline phosphatase, and prostate specific antigen in patients with a Gleason score ≥7;Medicine;2022-06-24